GlakoLens has successfully applied for the fifth and final cohort of South Bank Innovation’s Simulation for Digital Health (SimDH) programme.
SimDH aims to fast-track London-based digital health start-ups and SMEs through to the next stage of their business journey and/or help them to develop new-to-market products and services. This achieved by sharing the academic knowledge within London South Bank University (LSBU) and the varied experience of our expert industry partners.
GlakoLens joined the SimDH programme to further improve its product and service offering to ophthalmologists, hospitals and glaucoma patients. Along the process, GlakoLens will also evaluate and fine-tune its go-2-market strategies in the UK and Europe.
GlakoLens will be following in the footsteps of over 120 health tech SMEs who have already been supported by SimDH in areas such as diagnostics and monitoring, artificial intelligence, pain and disease management and mental health wellbeing.
The programme, delivered in partnership with SEHTA, involves five months of webinars, consultancy, mentoring and support and we can’t wait to get started!
SimDH is co-funded by the European Regional Development Fund and LSBU.
